<SEC-DOCUMENT>0001193125-26-038119.txt : 20260205
<SEC-HEADER>0001193125-26-038119.hdr.sgml : 20260205
<ACCEPTANCE-DATETIME>20260204211611
ACCESSION NUMBER:		0001193125-26-038119
CONFORMED SUBMISSION TYPE:	425
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260205
DATE AS OF CHANGE:		20260204

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SILICON LABORATORIES INC.
		CENTRAL INDEX KEY:			0001038074
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				742793174
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		425
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29823
		FILM NUMBER:		26600109

	BUSINESS ADDRESS:	
		STREET 1:		400 W CESAR CHAVEZ
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701
		BUSINESS PHONE:		5124168500

	MAIL ADDRESS:	
		STREET 1:		400 W CESAR CHAVEZ
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78701

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SILICON LABORATORIES INC
		DATE OF NAME CHANGE:	20000105

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS INSTRUMENTS INC
		CENTRAL INDEX KEY:			0000097476
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				750289970
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		425

	BUSINESS ADDRESS:	
		STREET 1:		P.O. BOX 660199
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75266
		BUSINESS PHONE:		9729953773

	MAIL ADDRESS:	
		STREET 1:		12500 TI BLVD
		STREET 2:		PO BOX 660199
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75266
</SEC-HEADER>
<DOCUMENT>
<TYPE>425
<SEQUENCE>1
<FILENAME>d48553d425.htm
<DESCRIPTION>425
<TEXT>
<HTML><HEAD>
<TITLE>425</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">FILED BY TEXAS INSTRUMENTS INCORPORATED </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">PURSUANT TO RULE&nbsp;425 UNDER THE SECURITIES ACT OF 1933 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">AND DEEMED FILED PURSUANT TO <FONT STYLE="white-space:nowrap">RULE&nbsp;14a-12</FONT> AND
<FONT STYLE="white-space:nowrap">RULE&nbsp;14d-2(b)</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">UNDER THE SECURITIES EXCHANGE ACT OF 1934 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">SUBJECT COMPANY: SILICON LABORATORIES INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">COMMISSION FILE NO. <FONT STYLE="white-space:nowrap">000-29823</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>From:</B> Matt Johnson &lt;<U>Matt.Johnson@silabs.com</U>&gt; <B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Date:</B> February&nbsp;4, 2026 at 2:01:42 PM CST <B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>To:</B> &#8220;DL.All&#8221; &lt;<U>DL.All@silabs.com</U>&gt; <B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subject:</B> <B>A Message from TI CEO Haviv Ilan | Excited about our future together</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Team, I&nbsp;joined Haviv this morning in Dallas for the&nbsp;announcement,&nbsp;and he asked me to share this with all of you.&nbsp;I also encourage you
to read more about our next chapter on <U>The Circuit.</U></I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>- Matt</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>_____________________________________________________________________________________</I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Silicon Labs Team, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I want to begin by saying how much I
respect what you have built at&nbsp;Silicon Labs. Your team has earned&nbsp;a strong reputation&nbsp;because of your technical&nbsp;expertise, winning&nbsp;spirit&nbsp;and impressive results.&nbsp;It is clear
that&nbsp;Silicon&nbsp;Labs&#8217;&nbsp;success is powered by exceptional people, and it will be a privilege to shape the next chapter&nbsp;alongside you.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Together,&nbsp;we&nbsp;will create a global leader in embedded wireless connectivity solutions &#8211; combining&nbsp;Silicon Labs&#8217;&nbsp;portfolio
and&nbsp;expertise&nbsp;in&nbsp;mixed-signal solutions with&nbsp;Texas Instruments&#8217;&nbsp;leading analog and embedded processing portfolio and&nbsp;our&nbsp;internally owned technology and manufacturing capabilities.&nbsp;Working
together&nbsp;expands our ability to serve customers worldwide, delivering greater scale, deeper end&nbsp;market&nbsp;expertise&nbsp;and enhanced value and support.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">What&#8217;s&nbsp;also important is how we achieve these results, and I believe that starts with the culture we create. Our two teams share common values and
ethical principles that define who we are and how we behave. We are both driven by our love of solving customer challenges, innovating, engineering excellence and delivering cutting-edge technologies to customers. Above all, we are both committed to
bringing out the best in our people and our communities. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I will be in Austin&nbsp;on&nbsp;Friday&nbsp;morning&nbsp;to visit with the team&nbsp;locally and around the
world&nbsp;and am looking forward to meeting many of you and hearing from you then.&nbsp;You may have&nbsp;questions&nbsp;on&nbsp;what&nbsp;it&#8217;s&nbsp;like to be a&nbsp;TIer&nbsp;and&nbsp;the integration process.&nbsp;Having joined&nbsp;Texas
Instruments&nbsp;from an&nbsp;acquisition&nbsp;earlier in my career,&nbsp;I can tell you&nbsp;that&nbsp;TI&nbsp;has&nbsp;been a&nbsp;welcoming work environment and&nbsp;great place&nbsp;to grow a career, filled with challenging and meaningful
work.&nbsp;Our culture is anchored in doing what you love, making an&nbsp;impact&nbsp;and continuously growing.&nbsp;We&nbsp;are eager to share this with you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">- Haviv</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #cc0000">&nbsp;</DIV> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g48553g20v72.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the proposed transaction, Silicon Laboratories Inc. (&#8220;Silicon Labs) plans to file a proxy statement with the Securities and Exchange
Commission (the &#8220;SEC&#8221;)&nbsp;with respect to a special meeting of stockholders for purposes of obtaining stockholder approval of the proposed transaction. This communication is not a substitute for the proxy statement or any other
document that Silicon Labs may file with the SEC. The definitive proxy statement (when available) will be sent or given to the stockholders of Silicon Labs and will contain important information about the&nbsp;proposed transaction&nbsp;and related
matters. STOCKHOLDERS OF SILICON LABS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO AND ANY DOCUMENTS INCORPORATED BY REFERENCE THEREIN) AND OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE PROPOSED
TRANSACTION THAT SILICON LABS WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION. Stockholders and investors will be able to
obtain free copies of the proxy statement and other relevant materials (when available) and other documents filed by Silicon Labs&nbsp;at&nbsp;the SEC&#8217;s website at <U>www.sec.gov</U>. Copies of the proxy statement (when available) and the
filings that will be incorporated by reference therein may also be obtained, without charge, by contacting Silicon Labs&#8217; Investor Relations at&nbsp;<U>investor.relations@silabs.com</U>&nbsp;or (512)
<FONT STYLE="white-space:nowrap">416-8500.</FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the Solicitation</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Silicon Labs, Texas Instruments Incorporated (&#8220;Texas Instruments&#8221;)&nbsp;and their respective directors and executive officers may be deemed, under
SEC rules, to be participants in the solicitation of proxies in respect of the proposed transaction.&nbsp;Information regarding&nbsp;Silicon Labs&#8217;&nbsp;directors and executive officers is available in (a)&nbsp;Silicon Labs&#8217;&nbsp;Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;28, 2024, including under the headings &#8220;Item 10. Directors, Executive Officers and Corporate Governance,&#8221; &#8220;Item 11. Executive
Compensation,&#8221; &#8220;Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters&#8221; and &#8220;Item 13. Certain Relationships, Related Transactions, and Director Independence,&#8221; which was
filed with the SEC on February&nbsp;4, 2025, and can be found at <U>www.sec.gov</U>; (b)&nbsp;Silicon Labs&#8217;&nbsp;definitive proxy statement for its 2025 annual meeting of stockholders, which was filed with the SEC on March&nbsp;12, 2025, under
the headings &#8220;Proposal One: Election of Directors,&#8221; &#8220;Ownership of Securities,&#8221; &#8220;Executive Officers,&#8221; and &#8220;Compensation Discussion and Analysis,&#8221; and can be found at <U>www.sec.gov</U>; and
(c)&nbsp;subsequently filed Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q.</FONT> To the extent holdings of&nbsp;Silicon Labs&#8217;&nbsp;securities by its
directors or executive officers have changed since the amounts set forth in&nbsp;Silicon Labs&#8217;&nbsp;proxy statement for its 2025 annual meeting of stockholders, such changes have been or will be reflected on Forms 3, 4 and 5, filed with the
SEC (which can be found at <U>www.sec.gov</U>).&nbsp;Copies of the documents filed with the SEC by Silicon Labs will be available free of charge through the website maintained by the SEC and at&nbsp;Silicon Labs&#8217;&nbsp;website at
<U>https://investor.silabs.com</U>/.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information regarding Texas Instruments&#8217; directors and executive officers is available in (a)&nbsp;Texas
Instruments&#8217; Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2024, including under the headings&nbsp;&#8220;ITEM 10. Directors, executive officers and corporate governance,&#8221;
&#8220;ITEM 11. Executive compensation,&#8221; &#8220;ITEM 12. Security ownership of certain beneficial owners and management and related stockholder matters&#8221; and &#8220;ITEM 13.&nbsp;Certain relationships and related transactions, and
director independence,&#8221;&nbsp;which was filed with the SEC on February&nbsp;14, 2025, and can be found at <U>www.sec.gov</U>; (b)&nbsp;Texas Instruments&#8217; definitive proxy statement for its 2025 annual meeting of stockholders, which was
filed with the SEC on March&nbsp;5, 2025, under the headings &#8220;Election of directors,&#8221; &#8220;Executive compensation,&#8221; and &#8220;Security ownership of directors and management,&#8221; and can be found at <U>www.sec.gov</U>; and
(c)&nbsp;subsequently filed Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q.</FONT> To the extent holdings of Texas Instruments&#8217; securities by its
directors or executive officers have changed since the amounts set forth in Texas </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Instruments&#8217; proxy statement for its 2025 annual meeting of stockholders, such changes have been or will be reflected on Forms 3, 4 and 5, filed with the SEC (which can be found at
<U>www.sec.gov</U>). Copies of the documents filed with the SEC by Texas Instruments will be available free of charge through the website maintained by the SEC at <U>www.sec.gov</U> and at Texas Instruments&#8217; website at
<U>https://investor.ti.com/</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other information regarding the participants in the solicitation and a description of their direct and indirect
interests, by security holdings or otherwise, will be set forth in&nbsp;Silicon Labs&#8217;&nbsp;definitive proxy statement and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials become
available.&nbsp;Investors and stockholders should read the proxy statement carefully when it becomes available before making any voting or investment decisions.&nbsp;Copies of these documents may be obtained, free of charge, from the sources
indicated above.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Offer or Solicitation</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
communication is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of
Section&nbsp;10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding
Forward-Looking Statements</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains &#8220;forward-looking statements&#8221; within the meaning of&nbsp;of Section&nbsp;27A of the
Securities Act of 1933, as amended, Rule 175 promulgated thereunder, Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, and Rule <FONT STYLE="white-space:nowrap">3b-6</FONT> promulgated thereunder. Such statements include
statements concerning anticipated future events and expectations that are not historical facts. Any statements about&nbsp;Texas Instruments&#8217;&nbsp;or&nbsp;Silicon Labs&#8217;&nbsp;plans, objectives, expectations, strategies, beliefs, or future
performance or events constitute forward-looking statements. Forward-looking statements are typically identified by words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221;
&#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;positions,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;forecast,&#8221; &#8220;guidance,&#8221; &#8220;goal,&#8221; &#8220;objective,&#8221;
&#8220;prospects,&#8221; &#8220;possible&#8221; or &#8220;potential,&#8221; by future conditional verbs such as &#8220;assume,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;could&#8221; or &#8220;may,&#8221; or by
variations of such words or by similar expressions or the negative thereof. Such forward-looking statements </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
include but are not limited to statements about the benefits of the proposed transaction, including future financial and operating results,&nbsp;Texas Instruments&#8217;&nbsp;or&nbsp;Silicon
Labs&#8217;&nbsp;plans, objectives, expectations and intentions, the expected timing of completion of the proposed transaction and other statements that are not historical facts.&nbsp;Actual results may vary materially from those expressed or
implied by forward-looking statements based on a number of factors, including, without limitation: (a)&nbsp;risks related to the consummation of the&nbsp;proposed transaction, including the risks that (i)&nbsp;the&nbsp;proposed transaction&nbsp;may
not be consummated within the anticipated time period, or at all, (ii)&nbsp;the parties may fail to obtain&nbsp;Silicon Labs&nbsp;stockholder approval of the merger agreement, (iii)&nbsp;the parties may fail to secure the termination or expiration
of any waiting period applicable under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or obtain other required governmental and regulatory approvals, and (iv)&nbsp;other conditions to the consummation of the&nbsp;proposed
transaction&nbsp;under the merger agreement may not be satisfied; (b)&nbsp;the effects that any termination of the merger agreement may have on&nbsp;Silicon Labs&nbsp;or&nbsp;Texas Instruments&nbsp;and their respective businesses, including the risk
that&nbsp;Silicon Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;stock price may decline significantly if the&nbsp;proposed transaction&nbsp;is not completed; (c)&nbsp;the effects that the announcement or pendency of the&nbsp;proposed
transaction&nbsp;may have on&nbsp;Silicon Labs&nbsp;or&nbsp;Texas Instruments&nbsp;and their respective businesses, including the risks that as a result (i)&nbsp;Silicon Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;business, operating
results or stock price may suffer, (ii)&nbsp;Silicon Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;current plans and operations may be disrupted, (iii)&nbsp;Silicon Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;ability to retain or
recruit key employees may be adversely affected, (iv)&nbsp;Silicon Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;business relationships (including, customers and suppliers) may be adversely affected, or (v)&nbsp;Silicon
Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;management&#8217;s or employees&#8217; attention may be diverted from other important matters; (d)&nbsp;the effect of limitations that the merger agreement places on&nbsp;Silicon
Labs&#8217;&nbsp;ability to operate its business, return capital to stockholders or engage in alternative transactions; (e)&nbsp;the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such
proceedings related to the&nbsp;proposed transaction&nbsp;and instituted against&nbsp;Silicon Labs and others; (f)&nbsp;the risk that the&nbsp;proposed transaction&nbsp;and related transactions may involve unexpected costs, liabilities or delays;
(g)&nbsp;other economic, business, competitive, legal, regulatory, and/or tax factors,&nbsp;including the impact of the current global memory chip shortage; and (h)&nbsp;other factors described in the reports of (i)&nbsp;Silicon Labs filed with the
SEC, including but not limited to the risks described in&nbsp;Silicon Labs&#8217;&nbsp;Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for its fiscal year ended December&nbsp;28, 2024, which was filed with the SEC on
February&nbsp;4, 2025, and&nbsp;Silicon Labs&#8217;&nbsp;Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and that are otherwise described or updated from time to time in&nbsp;Silicon Labs&#8217;&nbsp;other filings with the
SEC and (ii)&nbsp;Texas Instruments&nbsp;filed with the SEC, including but </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not limited to the risks described in&nbsp;Texas Instruments&#8217;&nbsp;Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for its fiscal year ended December&nbsp;31, 2024, which
was filed with the SEC on February&nbsp;14, 2025, and&nbsp;Texas Instruments&#8217;&nbsp;Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and that are otherwise described or updated from time to time in other filings with the
SEC. All forward-looking statements attributable to Silicon Labs or Texas Instruments, or&nbsp;persons&nbsp;acting on&nbsp;Silicon Labs&#8217;&nbsp;or&nbsp;Texas Instruments&#8217;&nbsp;behalf, are expressly qualified in their entirety by this
cautionary statement. Further, each of Silicon Labs and&nbsp;Texas Instruments&nbsp;disclaims any obligation to update the information in this communication or to announce publicly the results of any revisions to any of the forward-looking
statements to reflect future events or developments, except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g48553g20v72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g48553g20v72.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  > *P# 1$  A$! Q$!_\0
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M_P 1_!/P-H'@SP]\7M;7POHLCRVUA)I5F"Q:5YMKRJ@D*>8Y)4,-P^4G:2*
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
